138 related articles for article (PubMed ID: 32719268)
1. Correlation of planning target volume with mucositis for head-and-neck cancer patients undergoing chemoradiation.
Manur JG; Vidyasagar N
J Cancer Res Ther; 2020; 16(3):565-568. PubMed ID: 32719268
[TBL] [Abstract][Full Text] [Related]
2. Volume changes during head-and-neck radiotherapy and its impact on the parotid dose - A single-institution observational study.
Ilangovan B; Venkatraman M; Balasundaram S
J Cancer Res Ther; 2020; 16(3):575-580. PubMed ID: 32719270
[TBL] [Abstract][Full Text] [Related]
3. Distinctive mucositis and feeding-tube dependency in cetuximab plus radiotherapy for head and neck cancer.
Yokota T; Onoe T; Ogawa H; Hamauchi S; Iida Y; Kamijo T; Suda T; Yurikusa T; Nishimura T; Yasui H; Onitsuka T
Jpn J Clin Oncol; 2015 Feb; 45(2):183-8. PubMed ID: 25420692
[TBL] [Abstract][Full Text] [Related]
4. Hyperfractionated accelerated radiotherapy with concomitant integrated boost of 70-75 Gy in 5 weeks for advanced head and neck cancer. A phase I dose escalation study.
Cvek J; Kubes J; Skacelikova E; Otahal B; Kominek P; Halamka M; Feltl D
Strahlenther Onkol; 2012 Aug; 188(8):666-70. PubMed ID: 22648405
[TBL] [Abstract][Full Text] [Related]
5. Role of concomitant chemoradiation in locally advanced head and neck cancers.
Lasrado S; Moras K; Pinto GJ; Bhat M; Hegde S; Sathian B; Luis NA
Asian Pac J Cancer Prev; 2014; 15(10):4147-52. PubMed ID: 24935361
[TBL] [Abstract][Full Text] [Related]
6. The efficacy of an ayurvedic preparation of yashtimadhu (
Mamgain RK; Gupta M; Mamgain P; Verma SK; Pruthi DS; Kandwal A; Saini S
J Cancer Res Ther; 2020; 16(3):458-462. PubMed ID: 32719251
[TBL] [Abstract][Full Text] [Related]
7. Acute toxicities experienced during simultaneous integrated boost intensity-modulated radiotherapy in head and neck cancers--experience from a north Indian regional cancer centre.
Chakraborty S; Ghoshal S; Patil V; Oinam A; Suresh S
Clin Oncol (R Coll Radiol); 2009 Nov; 21(9):676-86. PubMed ID: 19748768
[TBL] [Abstract][Full Text] [Related]
8. Comparison between normal tissue reactions and local tumor control in head and neck cancer patients treated by definitive radiotherapy.
Geara FB; Peters LJ; Ang KK; Garden AS; Tucker SL; Levy LB; Brown BW
Int J Radiat Oncol Biol Phys; 1996 Jun; 35(3):455-62. PubMed ID: 8655367
[TBL] [Abstract][Full Text] [Related]
9. Oral mucositis prevention by low-level laser therapy in head-and-neck cancer patients undergoing concurrent chemoradiotherapy: a phase III randomized study.
Gouvêa de Lima A; Villar RC; de Castro G; Antequera R; Gil E; Rosalmeida MC; Federico MH; Snitcovsky IM
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):270-5. PubMed ID: 21163585
[TBL] [Abstract][Full Text] [Related]
10. Role of benzydamine hydrochloride in the prevention of oral mucositis in head and neck cancer patients treated with radiotherapy (>50 Gy) with or without chemotherapy.
Rastogi M; Khurana R; Revannasiddaiah S; Jaiswal I; Nanda SS; Gupta P; Chufal KS; Bhatt ML
Support Care Cancer; 2017 May; 25(5):1439-1443. PubMed ID: 27987094
[TBL] [Abstract][Full Text] [Related]
11. Whole-Field Sequential Intensity-Modulated Radiotherapy for Local-Regional Advanced Head-and-Neck Squamous Cell Carcinoma.
Refaat T; Choi M; Thomas TO; Bacchus I; Agulnik M; Pelzer HJ; Mellott AL; Rademaker AW; Liu D; Sathiaseelan V; Mittal BB
Am J Clin Oncol; 2015 Dec; 38(6):588-94. PubMed ID: 24136140
[TBL] [Abstract][Full Text] [Related]
12. Functional and biochemical changes in the thyroid gland following exposure to therapeutic doses of external beam radiotherapy in the head-and-neck cancer patients.
Randhawa AS; Yadav HP; Banipal RPS; Goyal G; Garg P; Marcus S
J Cancer Res Ther; 2021; 17(4):1025-1030. PubMed ID: 34528559
[TBL] [Abstract][Full Text] [Related]
13. The impact of margin reduction on outcome and toxicity in head and neck cancer patients treated with image-guided volumetric modulated arc therapy (VMAT).
Navran A; Heemsbergen W; Janssen T; Hamming-Vrieze O; Jonker M; Zuur C; Verheij M; Remeijer P; Sonke JJ; van den Brekel M; Al-Mamgani A
Radiother Oncol; 2019 Jan; 130():25-31. PubMed ID: 30005953
[TBL] [Abstract][Full Text] [Related]
14. Long-term results of elective mucosal irradiation for head and neck cancer of unknown primary in Chinese population: The EMICUP study.
Dou S; Li R; Zhang L; Wang Z; Xie L; Zhang C; Zhu G
Cancer Med; 2020 Mar; 9(5):1712-1720. PubMed ID: 31953927
[TBL] [Abstract][Full Text] [Related]
15. Impact of intensity-modulated and image-guided radiotherapy on elderly patients undergoing chemoradiation for locally advanced head and neck cancer.
Nguyen NP; Vock J; Chi A; Vinh-Hung V; Dutta S; Ewell L; Jang S; Betz M; Almeida F; Miller M; Davis R; Sroka T; Vo RP; Karlsson U; Vos P
Strahlenther Onkol; 2012 Aug; 188(8):677-83. PubMed ID: 22659942
[TBL] [Abstract][Full Text] [Related]
16. The Indian Spice Turmeric Delays and Mitigates Radiation-Induced Oral Mucositis in Patients Undergoing Treatment for Head and Neck Cancer: An Investigational Study.
Rao S; Dinkar C; Vaishnav LK; Rao P; Rai MP; Fayad R; Baliga MS
Integr Cancer Ther; 2014 May; 13(3):201-10. PubMed ID: 24165896
[TBL] [Abstract][Full Text] [Related]
17. Assessment of Oral Mucositis among Patients Undergoing Radiotherapy for Head and Neck Cancer: An Audit.
Luitel A; Rimal J; Maharjan IK; Regmee P
Kathmandu Univ Med J (KUMJ); 2019 Jan.-Mar; 17(65):61-65. PubMed ID: 31734681
[TBL] [Abstract][Full Text] [Related]
18. Microvascular changes in radiation-induced oral mucositis.
Hamilton S; Yoo J; Hammond A; Read N; Venkatesan V; Franklin J; Fung K; Gray D; Parry N; Van Diepen K; Baswick BL; Badhwar A
J Otolaryngol Head Neck Surg; 2008 Oct; 37(5):730-7. PubMed ID: 19128685
[TBL] [Abstract][Full Text] [Related]
19. Beneficial Effects of Adjuvant Melatonin in Minimizing Oral Mucositis Complications in Head and Neck Cancer Patients Receiving Concurrent Chemoradiation.
Onseng K; Johns NP; Khuayjarernpanishk T; Subongkot S; Priprem A; Hurst C; Johns J
J Altern Complement Med; 2017 Dec; 23(12):957-963. PubMed ID: 28657801
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
